Trial Details

RECRUITING
Basic Information
Clinical ID c137
Identifier NCT07114055
Trial Title Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome - Diarrhoea
Interventions DRUG: ebastine|DRUG: Placebo
Participant Information
Sponsor Md. Hazrat Ali
City Dhaka
Country/Region Bangladesh
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2025-08-15
Primary Completion Date 2026-07
Completion Date 2026-07